壳交联pH响应型PLGA载药微球的制备与研究

首先采用一次乳化法制备出PLGA[聚(乳酸-羟基乙酸)]纳米微球,并通过静电吸附将阳离子聚合物壳聚糖修饰到PLGA微球表面,然后以香草醛为交联剂对壳聚糖进行化学交联,得到一种壳交联的p H响应型纳米微球(PCV),微球粒径为(277.60±38.01)nm,表面电位为(21.60±4.51)m V.微球稳定性评价结果显示微球在24 h内粒径变化较小;流式细胞仪检测显示细胞对PCV微球的摄取量比未经修饰的PLGA微球的摄取量高;空白微球细胞毒性实验表明在空白微球浓度小于80μg/m L时细胞的存活率达93.24%.以多西他赛(DTX)为模型药物进行包载,该纳米微球DTX的载药率为7.48%,包封率为34.98%;体外药物释放实验显示,该微球在p H=5.0环境下孵育90 h的药物积累释放率达58.66%,而在p H=7.4的环境下的药物积累释放率为50.63%;此外,载DTX微球毒性试验结果表明该载药微球对A549肺癌细胞有较强的杀伤作用,其IC50值可达0.0009μg/m L.     

模板聚合法制备高浓度PMAA/HEC核-壳聚合物纳米微球

以羟乙基纤维素(HEC)为大分子模板,选用甲基丙烯酸(MAA)单体,通过模板聚合一步反应,制备了较高浓度(40 mg/mL)的核-壳结构聚合物纳米微球溶液。采用透射电镜、红外光谱、粒径-电位和荧光光谱等分析方法,研究了PMAA/HEC纳米微球的形态、结构、原位形成机理和pH响应特性。结果表明:在大分子间氢键作用的驱动下,原位生成的PMAA和HEC自组装形成了以不溶性的PMAA/HEC大分子复合物为核、以可溶性HEC为壳的PMAA/HEC聚合物纳米微球。微球在pH=0.7~4.0范围内表现出较明显的pH敏感性。     

改性壳聚糖抗菌纳米微球的制备

以卤胺化合物为抗菌基团对壳聚糖接枝改性, 并制备成纳米微球, 提高壳聚糖的抗菌性能. 通过核磁共振和紫外光谱对改性壳聚糖进行结构表征; 探讨了改性壳聚糖浓度、 三聚磷酸钠浓度及两者体积比对纳米微球的形成和粒径分布的影响; 测定了纳米微球的抗菌性能. 结果表明, 在改性壳聚糖浓度为4.0 mg/mL, 三聚磷酸钠浓度为2.0 mg/mL时, 形成的纳米微球形态稳定, 粒径分布均匀, 氯化后的纳米微球可在30 min内杀灭10⁷ cfu(cfu为单位体积中的菌落总数)的金黄色葡萄球菌和大肠杆菌, 表现出优异的抗菌性能.     

聚乙二醇接枝聚乳酸的自组装纳米微球的制备及性能

对制备的新型聚乙二醇(PEG)接枝聚乳酸(PLA)在水中的自组装性能进行研究, 探讨其作为纳米药物载体的可行性和稳定性. 目测法得到其溶解度为(2.16～4.32)×10^－2 mg•mL^－1; 荧光法得到聚合物的临界胶束浓度为1.12×10^－3 mg•mL^－1; 透射电子显微镜观察显示该聚合物在水中的自组装聚集体为纳米级球形; 动态激光光散射测试微球的粒径和Zeta电位发现, 在微球的制备过程中, 聚合物的亲/疏水性比例、水相介质及水溶液的pH值对它影响显著; 而制备后, 稀释和冷冻对它无显著影响, 改变微球的环境pH值至酸性, 出现聚集, 至碱性无影响. 研究结果显示, 该聚合物在水和磷酸钠盐缓冲液中可形成稳定的纳米微球, 通过微球的制备条件和存在环境可控制其粒径和Zeta电位, 因此根据应用需要, 通过控制其粒径和Zeta电位, 可能提高微球的在体血液循环时间并实现靶向缓释.     

T型微通道装置制备单分散PLGA微球

利用微通道法乳化技术原理,研制了一个可拆卸T型玻璃微通道装置,以聚乙烯醇水溶液为连续相,聚(乳酸-co-羟基乙酸)(PLGA)的二氯甲烷溶液为分散相,制备了单分散的PLGA微球.考察了乳化剂用量、连续相和分散相流速以及PLGA浓度对形成的液滴平均粒径和变异系数(CV值)的影响.结果表明,增大乳化剂用量,提高连续相流速或降低分散相流速,制备得到的PLGA微球直径减小;分散相浓度在5～20 g/L之间变化时,其对微球直径的影响有限.PLGA微球表面光滑无孔,且内部是实心的.用本装置制备得到的PLGA微球,其粒径范围在30～200μm之间,CV值在15%以下,最低可至3%.该方法可使用挥发性有机溶剂作为分散相而且能避免微球制备时易堵塞等问题,可应用于药物缓控释领域中微米级单分散微球的制备.     

高分子微球偶联固定卡托普利药物分子的研究

采用无皂乳液聚合法制得聚苯乙烯-甲基丙烯酸缩水甘油酯(PSG)乳液微球,然后在微球表面嫁接空间臂分子1,6-己二胺,得到表面含氨基的PSGN微球,接着借助EDC/NHS催化作用将药物分子卡托普利化学偶联到PSGN微球表面,制成固定卡托普利的亲和PSG微球。实验着重考察了PSGN微球偶联固定卡托普利反应过程中催化剂比例和用量、pH值、反应温度和时间等的影响规律。结果表明,在25℃,pH为4.0,m(NHS)∶m(EDC)=1∶2,EDC的浓度为4mg/mL的条件下,卡托普利偶联到微球表面的效果较好。     

三聚氰胺甲醛微球的制备及模板法构建聚谷氨酸基微胶囊

以分散聚合法制备低交联度三聚氰胺甲醛(MF)微球, 研究了pH和反应时间等对MF微球粒径、表面电位和溶解性的影响. 以MF微球为模板, 采用层层自组装法交替吸附聚谷氨酸(PGA)和壳聚糖(CS), 构建中空的PGA/CS微胶囊. 采用偏光显微镜、纳米粒度及电位分析仪、红外和透射电镜等进行表征. 结果表明, MF粒径及表面电位随pH值降低而减小, 在盐酸中的溶解性随反应时间延长而变差. 在自组装过程中, 微球表面电位呈正负交替变化, 表明以静电力为主要驱动力制得的空心微胶囊粒径均匀, 分散良好, 模型药物罗丹明可成功载入其中, 有望成为优良的水溶性药物载体.     

肾上腺髓质素微球复合PLGA/纳米轻基磷灰石支架材料的制备及生物活性评价

利用离子乳化交联法制备了负载肾上腺髓质素的壳聚糖微球,应用热致相分离法制备了乳酸和乙醇酸共聚物/纳米羟基磷灰石(PLGA/nHA)支架材料并在其中包覆载药微球.通过扫描电子显微镜、体外释放行为、材料溶血行为、碱性磷酸酶(ALP)活性的测定、支架材料表面细胞荧光染色和MTT[3-(4,5-二甲基噻唑-2)-2,5-二苯基...     

可降解聚乙交酯-丙交酯缓释微球用于甲状旁腺相关肽的持续释放

采用水包油包水(W1/O/W2)复乳溶剂挥发法制备了包载甲状旁腺激素相关肽(PTHrP)的聚乙交酯-丙交酯(PLGA)微球,通过核磁,红外,GPC,扫描电子显微镜等观察PLGA载药微球的结构,表明载药微球具有良好的球形结构,其平均粒径约为8μm.而体外模拟释放表明,此PLGA载药微球能实现PTHrP1-34长达25天的持续释放.并通过MTT法、碱性磷酸酶活性测定等检测负载PTHrP1-34的PLGA微球缓释系统对小鼠成骨细胞MC3T3-E1增殖及分化的影响,结果表明PTHrP1-34浓度为1×10-9mol/L时对MC3T3-E1增殖促进效应最大,且随着药物作用时间的延长,缓释系统促进细胞增殖、分化的作用越明显.     

胃蛋白酶对CdTe纳米粒子的表面修饰及分析应用

以巯基乙酸为稳定剂和表面修饰剂, 在有机相中合成了平均粒径为3 nm左右的CdTe纳米粒子, 用胃蛋白酶改变纳米粒子的表面修饰状态并研究其系列特性. CdTe纳米粒子在320 nm处有强的紫外吸收, 在524.8 nm处有荧光发射. 经胃蛋白酶对其表面修饰后, 紫外吸收峰位不变, 但吸光强度升高, 荧光峰位蓝移至467.2 nm, 荧光强度降低. 温度、pH值及离子强度均对表面修饰产生影响. 在最佳实验条件下, 胃蛋白酶质量浓度在4—40 mg/L范围内与荧光降低值之间呈线性关系, 检测限(3σ)为0.28 mg/L(n=10), 该方法已被用于人体胃液胃蛋白酶的测定.     

In vivo NIR imaging with CdTe/CdSe quantum dots entrapped in PLGA nanospheres

Luminescent near-infrared (NIR) CdTe/CdSe QDs were synthesized and encapsulated in poly(lactic-co-glycolic acid) (PLGA) nanospheres to prepare stable and biocompatible QDs-loaded nanospheres for in vivo imaging. QDs were encapsulated with PLGA nanospheres by a solid dispersion method and optimized to have high fluorescence intensity for in vivo imaging detection. The resultant QDs-loaded PLGA nanospheres were characterized by various analytical techniques such as UV-Vis measurement, dynamic light scattering (DLS), fluorescence spectroscopy, and transmission electron microscopy (TEM). Finally, we evaluated toxicity and body distribution of QDs loaded in PLGA nanospheres in vitro and in vivo, respectively. From the results, the QDs loaded in PLGA nanospheres were spherical and showed a diameter range of 135.0-162.3 nm in size. The QD nanospheres increased their stability against photooxidation and photobleaching, which have the high potential for applications in biomedical imaging. We have also attained non-invasive in vivo imaging with light photons, representing an intriguing avenue for obtaining biological information by the use of NIR light.     

Surface modification of Mitoxantrone-loaded PLGA nanospheres with chitosan

The purpose of this research was to develop polylactic-co-glycolic acid (PLGA) nanospheres surface modified with chitosan (CS). Mitoxantrone- (MTO-) loaded PLGA nanospheres were prepared by a solvent evaporation technique. The PLGA nanospheres surface was modified with CS by two strategies (adsorption and covalent binding). PLGA nanospheres of 248.4 ± 21.0 nm in diameter characterized by the laser light scattering technique, scanning electron microscopy (SEM) are spherical and its drug encapsulation efficiency is 84.1 ± 3.4%. Zeta potential of unmodified nanospheres was measured to be negative −21.21 ± 2.13 mV. The positive zeta potential of modified nanospheres reveals the presence of CS on the surface of the modified nanospheres. Modified nanospheres were characterized for surface chemistry by X-ray photoelectron spectroscopy (XPS) and Fourier transform infrared (FT-IR). FT-IR spectra exhibited peaks at 3420 cm⁻¹ and 1570 cm⁻¹, XPS spectra shows the N 1s (atomic orbital 1s of nitrogen) region of the surface of the nanospheres, corresponding to the primary amide of CS. In vitro drug release demonstrated that CS-modified nanospheres have many advantages such as prolonged drug release property and decreased the burst release over the unmodified nanospheres, and the modified nanospheres by covalent binding method could achieve the release kinetics of a relatively constant release. These data demonstrate high potential of CS-modified PLGA nanospheres for the anticancer drug carrier.     

Nontoxic block copolymer nanospheres: design and characterization

Biodegradable polymers capable of self-assembly into hollow nanospheres of less than 100 nm have significant potential for biotechnology applications such as drug delivery and gene therapy. Here we describe the synthesis of a novel ABA-type triblock copolymer made from a hydrophobic tyrosine-derived core and two hydrophilic poly(ethylene glycol) end groups (poly(ethylene glycol)-block-oligo(desaminotyrosyltyrosine octyl ester suberate)-block-poly(ethylene glycol)). We describe the self-assembly of this triblock copolymer and characterize its particles as 100 nm size vesicular nanospheres. The vesicular nature of these particles was determined by light scattering and electron microscopy. The nanospheres did not exhibit any short-term cytotoxicity toward UMR-106 cells at a concentration up to 2 mg/mL.     

Size control of dendrimer-templated silica

One of the most significant challenges facing the biomimetic synthesis of materials is achieving the requisite level of dimensional and spatial control. Typical reaction conditions for biomimetic silica synthesis allow for continued growth and ripening leading to the formation of larger nanospheres on the order of 200-600 nm in diameter. Herein, we have used polyamidoamine and polypropylenimine dendrimers as templates to expand the reaction conditions of biogenic silica production to produce a more robust synthesis leading to size-selective precipitation of silica nanospheres. Through the use of defined concentrations of phosphate buffer and main group metal chloride salts, we have shown that the biomimetic silica growth process is controlled by cationic neutralization of the anionic silica nanosphere surface. Neutralization minimizes electrostatic repulsions, allowing for agglomerization and continued growth of nanospheres. By controlling these concentrations, we can selectively produce silica nanospheres of desired dimensions between 30 and 300 nm without adversely affecting the template's activity.     

5-氟尿嘧啶/壳聚糖载药纳米微球的制备及性能

以三聚磷酸钠为交联剂,采用离子交联法制备了5-氟尿嘧啶/壳聚糖纳米微球,评价其性能、体外释药性能及对人肺癌细胞GLC-82的体外杀伤效应,并通过Zeta电位和红外光谱分析载药纳米微球形成机理.结果表明,所制备的5-Fu/CS纳米微球平均包封率为32.3%,平均载药量为25.6%,平均粒径为253nm,平均zeta电势为+8.38mV,成球性及分散性良好.CS载药纳米微球具有缓释性能,体外释药行为符合双向动力学规律.在体外作用72h,CS载药纳米微球对人肺癌细胞GLC-82的杀伤率达66.6%,杀伤效果明显优于5-Fu对照组.     

Encapsulation of Local Anesthetic Bupivacaine in Biodegradable Poly(DL-lactide-co-glycolide) Nanospheres: Factorial Design,Characterization and Cytotoxicity Studies

Summary: Local anesthetic agents cause temporary blockade of nerve impulses productiong insensitivity to painful stimuli in the area supplied by that nerve. Bupivacaine (BVC) is an amide-type local anesthetic widely used in surgery and obstetrics for sustained peripheral and central nerve blockade. In this study, we prepared and characterized nanosphere formulations containing BVC. To achieve these goals, BVC loaded poly(DL-lactide-co-glycolide) (PLGA) nanospheres (NS) were prepared by nanopreciptation and characterized with regard to size distribution, drug loading and cytotoxicity assays. The 2^3-1 factorial experimental design was used to study the influence of three different independent variables on nanoparticle drug loading. BVC was assayed by HPLC, the particle size and zeta potential were determined by dynamic light scattering. BVC was determined using a combined ultrafiltration-centrifugation technique. The results of optimized formulations showed a narrow size distribution with a polydispersivity of 0.05%, an average diameter of 236.7 ± 2.6 nm and the zeta potential −2.93 ± 1,10 mV. In toxicity studies with fibroblast 3T3 cells, BVC loaded-PLGA-NS increased cell viability, in comparison with the effect produced by free BVC. In this way, BVC-loaded PLGA-NS decreased BVC toxicity. The development of BVC formulations in carriers such as nanospheres could offer the possibility of controlling drug delivery in biological systems, prolonging the anesthetic effect and reducing toxicity.     

Development of Multinuclear Polymeric Nanoparticles as Robust Protein Nanocarriers

One limitation of current biodegradable polymeric nanoparticles is their inability to effectively encapsulate and sustainably release proteins while maintaining protein bioactivity. Here we report the engineering of PLGA–polycation nanoparticles with a core–shell structure that act as a robust vector for the encapsulation and delivery of proteins and peptides. The optimized nanoparticles can load high amounts of proteins (>20 % of nanoparticles by weight) in aqueous solution without organic solvents through electrostatic interactions by simple mixing, thereby forming nanospheres in seconds with diameters <200 nm. The relationship between nanosphere size, surface charge, PLGA–polycation composition, and protein loading is also investigated. The stable nanosphere complexes contain multiple PLGA–polycation nanoparticles, surrounded by large amounts of protein. This study highlights a novel strategy for the delivery of proteins and other relevant molecules.     

Synthesis of mesoporous silica nanobamboo with highly dispersed tungsten carbide nanoparticles

By controlling the interaction between cationic surfactant micelles and ammonium metatungstate during the formation of mesoporous silica structure, highly dispersed tungsten carbide (WC) nanoparticles of 2.0 nm in diameter on mesoporous silica nanospheres were synthesized at lower concentration of ammonium metatungstate. With additional ammonium metatungstate, a novel mesoporous silica nanobamboo structure was formed with bimodal size-distributed WC nanoparticles, in which 2.0 nm WC was homogeneously distributed in nanobamboo's mesoporous silica wall and those with larger diameter (10.0-20.0 nm) were only formed on the nanobamboo's inner surface and at its internodes. The mesoporous silica nanobamboo also had a very high tensile strength due to its bamboo-like structure.     

Polymerizable Molecular Silsesquioxane Cage Armored Hybrid Microcapsules with In Situ Shell Functionalization

We prepared core–shell polymer–silsesquioxane hybrid microcapsules from cage‐like methacryloxypropyl silsesquioxanes (CMSQs) and styrene (St). The presence of CMSQ can moderately reduce the interfacial tension between St and water and help to emulsify the monomer prior to polymerization. Dynamic light scattering (DLS) and TEM analysis demonstrated that uniform core–shell latex particles were achieved. The polymer latex particles were subsequently transformed into well‐defined hollow nanospheres by removing the polystyrene (PS) core with 1:1 ethanol/cyclohexane. High‐resolution TEM and nitrogen adsorption–desorption analysis showed that the final nanospheres possessed hollow cavities and had porous shells; the pore size was approximately 2–3 nm. The nanospheres exhibited large surface areas (up to 486 m² g^?1) and preferential adsorption, and they demonstrated the highest reported methylene blue adsorption capacity (95.1 mg g^?1). Moreover, the uniform distribution of the methacryloyl moiety on the hollow nanospheres endowed them with more potential properties. These results could provide a new benchmark for preparing hollow microspheres by a facile one‐step template‐free method for various applications.     

Electrosurface properties of poly(ethylene terephthalate) films irradiated by heavy ions and track membranes based on these films

The streaming potential method realized in a slit-like setup using 10^–4–10^–2 mol/L KCl solutions has been employed to study the electrosurface characteristics of poly(ethylene terephthalate) films, both initial and irradiated by heavy ions, as well as track membranes with pore sizes of 50 and 210 nm made from these films. Their ζ potentials and surface charges have been calculated. The data obtained suggest that irradiation of the polymer films by heavy ions reduce the ζ potential and surface charge. However, as a result of film etching during the preparation of the track membranes, the ζ potential and surface charge increase and exceed the corresponding values for the initial film.